Starling Oncology (STLNW) Goodwill (2020 - 2026)

Starling Oncology (STLNW) has reported Goodwill for 7 consecutive years, with $7.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Goodwill changed 0.0% year-over-year to $7.2 million; the trailing twelve-month figure through Jun 2026 stood at $7.2 million (changed 0.0% YoY), and the FY2025 full-year result was $7.2 million, changed 0.0% from the prior year.
• Goodwill steadied at $7.2 million in Q2 2026 per STLNW's latest filing, from $7.2 million in the prior quarter.
• Across five years, Goodwill topped out at $34.5 million in Q2 2022 and bottomed at $4.6 million in Q1 2023.
• Historically, Goodwill has averaged $11.8 million across 5 years, with a median of $7.2 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Goodwill sank 82.91% in 2023, then surged 58.87% in 2024.
• Over 5 years, Goodwill stood at $21.4 million in 2022, then tumbled by 66.24% to $7.2 million in 2023, then changed by 0.0% to $7.2 million in 2024, then changed by 0.0% to $7.2 million in 2025, then changed by 0.0% to $7.2 million in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $7.2 million, $7.2 million, and $7.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.